4131.TWO NeoCore Technology Co., Ltd.
- Market cap
- TWD 1.22B
- P/E
- -
- P/B
- 4.25x
- ROE
- -1.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 4131.TWO undervalued?
Graham numberThe Graham number of NeoCore Technology Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NeoCore Technology Co., Ltd. fundamental analysis
No fundamental analysis for NeoCore Technology Co., Ltd. yet.
NeoCore Technology Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NeoCore Technology Co., Ltd.
NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety testing kits, including DR. Meat Kit, DR. Food-Ent kit, rapid test kit, and ELISA kit; infectious disease testing, such as DR. HPV Genotyping IVD Kit, DR. MTBC Screen IVD Kit, and DR. Microorganism IVD Kit (Non-sterile); and biochip instruments and equipment, including DR. AiM Reader, DR.Mini Oven, and DR.Fluidic Stat…
Full company profileNeoCore Technology Co., Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
NeoCore Technology Co., Ltd. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 88.9M | 89.0M | 64.7M | 61.5M | 383M |
| Gross Profit | 19.4M | 11.8M | -9.09M | 3.29M | 151M |
| Operating Income | -28.3M | -40.3M | -84.9M | -75.8M | 20.6M |
| EBITDA | - | -29.5M | -72.1M | -46.3M | 53.4M |
| Net Income | -17.2M | -28.2M | -64.6M | -48.1M | -2.76M |
| EPS | -0.91 | -1.49 | -1.64 | -1.22 | -0.07 |
| Balance Sheet | |||||
| Total Assets | 282M | 267M | 549M | 341M | 581M |
| Total Liabilities | 165M | 186M | 197M | 35.7M | 274M |
| Shareholders' Equity | 112M | 75.9M | 348M | 305M | 286M |
| Cash & Short-term Investments | 10.4M | 40.3M | 293M | 208M | 76.3M |
| Cash Flow | |||||
| Operating Cash Flow | -17.2M | -2.69M | -63.9M | -57.2M | -8.00M |
| Capital Expenditure | 0.00 | 737K | 11.5M | 12.5M | 6.76M |
| Free Cash Flow | -17.2M | -3.43M | -75.4M | -69.7M | -14.8M |
| Ratios | |||||
| ROE | -15.3% | -37.2% | -18.6% | -15.8% | -1.0% |
| ROA | -6.1% | -10.6% | -11.8% | -14.1% | -0.5% |
| Net Profit Margin | -19.3% | -31.7% | -99.9% | -78.2% | -0.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
NeoCore Technology Co., Ltd. dividends
NeoCore Technology Co., Ltd. has not paid dividends in the last 5 fiscal years.
Last stock split: 393.4404:1000 on Dec 29, 2021.
Who owns NeoCore Technology Co., Ltd.
- Insiders 75.02%
- Institutions 0.00%
- Public & others 24.98%
- Shares outstanding 39.8M
- Free float 12.0M
NeoCore Technology Co., Ltd. company profile
- Company name
- NeoCore Technology Co., Ltd.
- Ticker
- 4131.TWO
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- December
- Address
- No. 395, Linsen Road, Tainan City, Taiwan, 701
- Phone
- 886 3 3758 5585
- Website
- neocore.com.tw
About NeoCore Technology Co., Ltd.
NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety testing kits, including DR. Meat Kit, DR. Food-Ent kit, rapid test kit, and ELISA kit; infectious disease testing, such as DR. HPV Genotyping IVD Kit, DR. MTBC Screen IVD Kit, and DR. Microorganism IVD Kit (Non-sterile); and biochip instruments and equipment, including DR. AiM Reader, DR.Mini Oven, and DR.Fluidic Station. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and changed its name to NeoCore Technology Co., Ltd. in July 2023. NeoCore Technology Co., Ltd. was founded in 1987 and is headquartered in Tainan City, Taiwan.
NeoCore Technology Co., Ltd. management
3- Mr. Wen-Sheng JiGeneral Manager
- Jack LeeFinancial Legal Manager
- Yen-Chueh YangAdministration Department Manager